Continuous Chemotherapeutic Hyperthermic Peritoneal Perfusion

Known as: CHPP, continuous hyperthermic peritoneal perfusion 
A procedure that bathes the abdominal cavity in fluid that contains anticancer drugs. This fluid is warmer than body temperature. This procedure… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2017
0246819832017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Cytoreductive Surgery and Continuous Hyperthermic Peritoneal Perfusion in Patients with Mesothelioma and Peritoneal Carcinomatosis: Hemodynamic, Metabolic, and Anesthetic Considerations
Cytoreductive surgery and continuous hyperthermic peritoneal perfusion (CHPP) involve the conduct of a complex surgical procedure… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2003
2003
Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
PURPOSE Liver metastases are the sole or life-limiting component of disease in the majority of patients with ocular melanoma who… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
BACKGROUND/AIMS Although the most frequent cause of death after curative resection of advanced gastric cancer is peritoneal… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)
Background: Primary peritoneal mesothelioma is a locally aggressive disease that is difficult to treat or even palliate… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1999
1999
A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer
Purpose: Because intraperitoneal (i.p.) therapy may provide a therapeutic advantage and because hyperthermia enhances carboplatin… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
1996
1996
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination.
BACKGROUND The most common cause of noncurative resection and recurrence is gastric cancer is peritoneal seeding. However, the… (More)
Is this relevant?
1995
1995
Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer
Continuous hyperthermic peritoneal perfusion (CHPP) with a solution which contains 30 mg mitomycin C and 300 mg cisplatin has… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
BACKGROUND Continuous hyperthermic peritoneal perfusion (CHPP) with a solution that contained 10 micrograms/ml mitomycin C was… (More)
Is this relevant?
1994
1994
Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study
We performed continuous hyperthermic peritoneal perfusion (CHPP) or continuous normothermic peritoneal perfusion (CNPP) combined… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C.
Continuous hyperthermic peritoneal perfusion (CHPP) with a solution that contains mitomycin C (CHPP-M) has been clinically… (More)
Is this relevant?